Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2025-12-25 @ 12:33 AM
NCT ID:
NCT00681967
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent
* Age over 18 years
* Histologically proven squamous cell cancer of the head \& neck (SCCHN)
* Indication for postoperative Radiotherapy: pT3, pT4, pN2b, pN2c, pN3
Exclusion Criteria:
* Hypersensitivity to ZD1839 or any of the excipients of this product
* Tumour stage M1
* Co-existing malignancies diagnosed within the last 5 years. Exceptions: basal cell carcinoma, cervical cancer in situ
* Absolute neutrophil counts \<1.5 x 109
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00681967
Study Brief:
Protocol Section:
NCT00681967